translate English to French: Two cases were recently published of liver failure in patients receiving combination therapy with RI and PY for latent TB; one patient died.3 The Canadian Adverse Drug Reaction Monitoring Program (CADRMP) reviewed 420 suspected domestic reports of hepatobiliary adverse reactions associated with different combinations of INH, PY and RI that were received from the time of their introduction in Canada to May 18, 2001.
Un des patients est mort3. Le Programme canadien de surveillance des effets indésirables des médicaments (PCSEIM) a étudié 420 déclarations canadiennes portant sur des effets hépatobiliaires indésirables soupçonnés associés à différentes combinaisons d'INH, de PY et de RI qu'il a reçues depuis le lancement de ces produits au Canada, jusqu'au18 mai 2001.